Track the 华兰生物 share price and the full management transaction log of the company, a listed issuer based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 华兰生物 has published 3 insider filings. Market capitalisation: €24.2bn. The latest transaction was reported on 19 July 2024 (Purchase). Among the most active insiders: 安康. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
华兰生物 es una empresa especializada en el sector de la salud y farmacéutico. Cotiza en el mercado XSHE.